Family Medicine Doctors in Rockledge, PA Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Dr. Emily Abramson-chen, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 888 Fox Chase Rd, Rockledge, PA 19046 Phone: 215-379-6772 |
 Charles Martin Bolno, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 404b Huntingdon Pike, Rockledge, PA 19046 Phone: 215-663-1555 Fax: 215-663-1013 |
Dr. Ben J Kochuveli, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 8 Huntingdon Pike, 100, Rockledge, PA 19046 Phone: 215-663-8880 Fax: 215-663-8898 |
News Archive
Freescale Semiconductor receives ZigBee Certification for wireless health and wellness solutions
Freescale Semiconductor today announced it has received ZigBee Certified product status for its ZigBee Health Care wireless health and wellness processing platforms. The ZigBee Certified products status is awarded to products that have been tested and met criteria for interoperability that enable wireless devices to securely and reliably monitor and manage noncritical, low-acuity health care services.
Lab-grown, testosterone-producing cells could help treat hypogonadism
Researchers have managed to grow human, testosterone-producing cells, which could lead to improved treatment options for low testosterone levels.
Study looks at dabigatran adherence across Veterans Health Administration sites
Among patients with atrial fibrillation who filled prescriptions for the anticoagulant dabigatran at Veterans Health Administration sites, there was variability in patient medication adherence across sites, with appropriate patient selection and pharmacist-led monitoring associated with greater adherence to the medication, according to a study in the April 14 issue of JAMA.
Positive results from Incyte's COMFORT-I INCB18424 pivotal Phase III clinical trial in myelofibrosis
Incyte Corporation announced today positive top-line results from COMFORT-I, the pivotal Phase III clinical trial of INCB18424 (also known as INC424) in patients with myelofibrosis (MF) being conducted under a Food and Drug Administration (FDA) Special Protocol Assessment (SPA) Agreement. COMFORT-I (COntrolled MyeloFibrosis Study with ORal JAK Inhibitor Treatment) is a double-blind, placebo-controlled Phase III trial involving 309 patients.
› Verified 2 days ago